Arizona's First Genio Hypoglossal Nerve Stimulation Procedure Performed in Scottsdale

Leading Sleep Surgeon Dr. Jordan Weiner Brings Cutting-Edge CPAP Alternative to Arizona Patients

Published on Feb. 14, 2026

Got story updates? Submit your updates here. ›

Dr. Jordan S. Weiner, a board-certified otolaryngologist and president of Valley ENT, has performed Arizona's first Nyxoah Genio® hypoglossal nerve stimulation procedure. This FDA-approved treatment offers a new option for patients with obstructive sleep apnea who cannot tolerate CPAP. The procedure, completed at North Valley Surgery Center, represents a significant advancement in sleep apnea treatment for Arizona residents.

Why it matters

Genio uses bilateral hypoglossal nerve stimulation powered by an external wearable patch instead of an implanted battery, providing a new treatment option for sleep apnea patients who cannot tolerate or have not found success with traditional CPAP therapy. As the technology is newly FDA-approved, adoption has been selective, with only around two dozen surgeons nationwide trained to perform the Genio procedure.

The details

The Genio procedure stimulates both branches of the hypoglossal nerve at once, moving the tongue forward to keep the airway open. Unlike traditional hypoglossal nerve stimulation devices with implanted batteries, Genio is powered externally by a disposable adhesive patch worn under the chin during sleep. This allows for hardware upgrades to be completed by providing updated chips to patients, without the need for additional surgery.

  • Dr. Weiner performed Arizona's first Genio procedure in February 2026.
  • Genio received FDA approval in 2023 after clinical trials showed significant improvements in sleep apnea severity and oxygen levels.

The players

Dr. Jordan S. Weiner

A board-certified otolaryngologist specializing in sleep apnea surgery, and the president of Valley ENT and founder of Weiner Sleep Surgery, PLLC. Dr. Weiner has performed more than 500 hypoglossal nerve stimulation procedures and is recognized nationally for his expertise in sleep apnea surgery.

Nyxoah Genio®

An FDA-approved hypoglossal nerve stimulation device that uses bilateral stimulation powered by an external wearable patch instead of an implanted battery.

North Valley Surgery Center

The facility where Dr. Weiner performed Arizona's first Genio procedure.

Got photos? Submit your photos here. ›

What they’re saying

“Many patients with moderate to severe sleep apnea either can't tolerate CPAP or have tried it for months without success. These individuals often feel they're out of options. Genio offers a new path forward, particularly for patients who may be concerned about implanted batteries or who want bilateral tongue stimulation.”

— Dr. Jordan S. Weiner, Board-certified otolaryngologist and president of Valley ENT (natlawreview.com)

“We're at the leading edge with this technology. Not every state has a trained Genio surgeon yet. The training investment is significant, and the procedure is technically demanding, which is why adoption has been selective.”

— Dr. Jordan S. Weiner, Board-certified otolaryngologist and president of Valley ENT (natlawreview.com)

What’s next

As the Genio technology is newly FDA-approved, even the most experienced Genio surgeons have completed only a limited number of procedures. Dr. Weiner's successful performance of Arizona's first Genio procedure represents a significant milestone in the adoption of this innovative sleep apnea treatment option for patients in the state.

The takeaway

The introduction of the Genio hypoglossal nerve stimulation device in Arizona provides a new and promising alternative to CPAP therapy for patients with moderate to severe obstructive sleep apnea who have been unable to tolerate or find success with traditional treatment options. Dr. Weiner's expertise in this cutting-edge technology positions him as a leader in advancing sleep apnea care in the region.